SCHEMBL1825890

SCHEMBL1825890

Cc1ccc(NC(=O)c2ccc3nccnc3c2)cc1Nc1nccn1-c1cc(NC2CC2)ncn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 9/20 0.52
KDR P35968 9/20 0.52
LYN P07948 7/20 0.52
SRC P12931 7/20 0.52
INSR P06213 6/20 0.52
HCK P08631 6/20 0.52
BRAF P15056 2/20 0.45
MAPK14 Q16539 5/20 0.44
BTK Q06187 2/20 0.43
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
NFKB1 P19838 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3232951 0.89 LCK (0.56) LCKKDRLYNSRCINSR
SCHEMBL1829414 0.88 LCK (0.49) LCKKDRLYNSRCINSR
SCHEMBL1822389 0.88 MAPK14 (0.53) LCKKDRLYNSRCINSR
SCHEMBL1824965 0.88 LYN (0.58) LCKKDRLYNSRCINSR
SCHEMBL1823112 0.87 HCK (0.49) LCKKDRLYNSRCINSR
SCHEMBL13269757 0.87 HCK (0.45) LCKKDRLYNSRCINSR
SCHEMBL19153235 0.85 INSR (0.54) LCKKDRLYNSRCINSR
SCHEMBL13301785 0.85 SRC (0.48) LCKKDRLYNSRCINSR
SCHEMBL3238280 0.85 BRAF (0.57) LCKKDRLYNSRCINSR
SCHEMBL13292002 0.85 NPC1 (0.47) LCKKDRLYNSRCINSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4688876-B2 2011-05-25 JP claimed
US-7745437-B2 Compounds and compositions as protein kinase inhibitors IRM LLC (BM) 2010-06-29 US disclosed
US-7745437-B2 Compounds and compositions as protein kinase inhibitors IRM LLC (BM) 2010-06-29 US disclosed